FTIR Spectroscopy of Human Capillary Blood Serum
A study analyzed capillary blood serum from 52 MS patients and 52 matched healthy controls using FTIR spectroscopy. The technique identified metabolic differences, showing higher levels of phospholipids/lipids, nucleic acids, and Amide I/II in MS patients with accuracy, sensitivity, and specificity of 87.5%.
- Tags
- #MSResearch
- Most relevant to
- —
Why it matters
This research suggests FTIR spectroscopy could serve as a potential diagnostic tool for distinguishing MS from healthy individuals, highlighting biochemical alterations associated with the condition.
What this does not prove
As this is the first study using capillary blood serum for MS classification via FTIR, further validation in diverse populations is necessary to support the findings.
Next milestone
No next milestone was established from the available source.
Study facts
- Study design
- Not reported
- Participants / samples
- Not reported
- Randomised
- Not reported
- Controlled
- Yes
- Primary endpoint met
- Not reported
- Relevant MS type
- Not reported
- Publication date
- 2026-09-10
- Evidence reviewed
- Abstract only
- Regulatory approval
- Not reported
- Research areas
- Not classified
Original sources
- Primary evidenceCapillary serum-based spectroscopic signature for multiple sclerosis: A novel diagnostic perspective. ↗DOI: 10.1016/j.plabm.2026.e00553
Supporting passages (8)
subjectsMETHODS: The study included 52 patients with confirmed MS and 52 healthy control participants, matched by sex and age.
controlledMETHODS: The study included 52 patients with confirmed MS and 52 healthy control participants, matched by sex and age.
publication datePublication date: 2026-09-10
interventionOBJECTIVE: To analyze the biochemical characteristics of capillary blood-derived serum using Fourier-transform infrared (FTIR) spectroscopy, aiming to differentiate individuals diagnosed with Multiple Sclerosis (MS) from a matched control group (CG).
comparatorMETHODS: The study included 52 patients with confirmed MS and 52 healthy control participants, matched by sex and age.
primary endpointOBJECTIVE: To analyze the biochemical characteristics of capillary blood-derived serum using Fourier-transform infrared (FTIR) spectroscopy, aiming to differentiate individuals diagnosed with Multiple Sclerosis (MS) from a matched control group (CG).
findingsRESULTS: FTIR spectroscopy combined with supervised machine learning revealed metabolic alterations between groups, including increased concentrations of phospholipids/lipids, nucleic acids, and Amide I/II in MS patients.
limitationsTitle: Capillary serum-based spectroscopic signature for multiple sclerosis: A novel diagnostic perspective.
AI assessment, not yet reviewed by a person · version 1 · Community votes are separate from evidence review.